Katana VentraIP

List of COVID-19 vaccine authorizations

National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.

For COVID-19 vaccination policy by country, see Vaccination policy § Table.

Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK.[1] Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.[2]


Of the 40 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.


Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.[3][4][5]

[147]

World Health Organization

Hong Kong[177]

[594]

The CoronaVac COVID-19 vaccine is an inactivated virus vaccine[590] produced by the Chinese company Sinovac Biotech.[590][591][592]



Non-country entities

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Sputnik Light is a viral vector vaccine,[701] produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.[702]

[147][735]

World Health Organization

Convidecia is a viral vector vaccine[727] produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.



Non-country entities

Hong Kong

[152]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Cambodia

[745]

Colombia

[746]

Guyana[748]

[747]

Malaysia

[585]

New Zealand

[367]

St. Lucia

[490]

Turkey

[315]

Uruguay (only if accepted in the country of the person's origin)

[499]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Hong Kong

[152]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Guyana[748]

[747]

Hungary

[764]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

CoviVac is an inactivated virus vaccine[701] produced by the Chumakov Centre at the Russian Academy of Sciences.[765]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.[768]

Hong Kong

[152]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.[772]

Belize

[777]

Indonesia

[778]

Malaysia

[585]

New Zealand

[367]

Palau

[779]

Thailand

[695]

Turkey

[315]

MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.[774]


1. Somaliland[776]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.[661][780]

Malaysia

[585]

New Zealand

[367]

Hungary

[784]

Turkey

[785]

COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.[782]

Hong Kong

[152]

New Zealand

[367]

Turkey

[315]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.[787]

Hungary

[784]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Hungary

[764]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.[789]

Hungary

[784]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Malaysia

[585]

New Zealand

[367]

Malaysia

[585]

Turkey

[315]

Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.[792]

Guyana[748]

[747]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.[793]

Malaysia

[585]

New Zealand

[367]

Turkey

[315]

CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name Covifenz Archived 24 February 2022 at the Wayback Machine.

Malaysia

[585]

Turkey

[315]

Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.